Alt tag Alt tag
Alt tag Alt tag
Nubeqa Bayer

NUBEQA RESOURCES

Deciding if NUBEQA is right for you? Hear others talk about their experiences with NUBEQA and download resources designed to help you navigate your treatment path.

Alt tag

DOWNLOADABLE RESOURCES

Non-metastatic castration-resistant prostate cancer (nmCRPC)

Prostate cancer that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone.

NUBEQA (darolutamide) patient brochure thumbnail. NUBEQA (darolutamide) patient brochure thumbnail.

NUBEQA patient brochure (English)

NUBEQA (darolutamide) Spanish patient brochure is coming soon. NUBEQA (darolutamide) Spanish patient brochure is coming soon.

NUBEQA patient brochure (Spanish)

Questions to ask your doctor about NUBEQA (darolutamide) thumbnail. Questions to ask your doctor about NUBEQA (darolutamide) thumbnail.

Questions to ask your doctor

Metastatic hormone-sensitive prostate cancer (mHSPC)

Prostate cancer that has spread to other parts of the body and still responds to medical or surgical treatment that lowers testosterone.

NUBEQA (darolutamide) patient brochure thumbnail. NUBEQA (darolutamide) patient brochure thumbnail.

NUBEQA patient brochure (English)

NUBEQA (darolutamide) Spanish patient brochure is coming soon. NUBEQA (darolutamide) Spanish patient brochure is coming soon.

NUBEQA patient brochure (Spanish)

Questions to ask your doctor about NUBEQA (darolutamide) thumbnail. Questions to ask your doctor about NUBEQA (darolutamide) thumbnail.

Questions to ask your doctor

HELPFUL TIPS

Notepad icon reminder for NUBEQA (darolutamide) patients to take notes at each doctors’ appointment.

Take notes at each visit with your doctor so you can refer to them later

Calendar icon represents a patient tip to set reminders when you need to take NUBEQA.

Set a reminder on your phone to let you know when to take NUBEQA

Book icon represents patient tip: Ask your doctor for a NUBEQA patient starter kit.

Ask your doctor for a NUBEQA patient starter kit for additional support

Telephone icon tip for NUBEQA patients to save the Access Services by Bayer™ number in their phone.

Save the Access Services by Bayer™ number in your phone so it doesn't appear as spam, and answer all calls from the program

Utensils icon tip: Practice healthy habits such as aerobic exercise and strength training.

Practice healthy habits such as aerobic exercise and strength training. Your care team can help tailor a program for you

Light bulb icon patient tip: learn about conditions.

Some men find it helpful to learn as much as possible about their cancer. Click here for a list of organizations that offer information about cancer

NUBEQA: AS SEEN ON TV

Approved for men with nmCRPC and mHSPC*

*NUBEQA is approved to treat mHSPC in combination with docetaxel.

Thumbnail image for video on Nubeqa for patients with nmCRPC
Thumbnail image for video on Nubeqa for patients with mHSPC in combination with docetaxel.
Full Prescribing Information

FOR PEOPLE WHO CARE FOR SOMEONE WITH PROSTATE CANCER

TAKE CARE OF YOURSELF

Caring for a person with cancer can be difficult. You may have many feelings that can affect you in many ways. It's important to make sure you care for yourself as well. Taking care of yourself will help you to give the best support to your loved one.

Here are some ways to deal with the stress of caring for someone with cancer:

CAREGIVER TIPS

Blue and grey icon of a person with an apple inside a blue circle.

Eat healthy and exercise

Blue and grey icon with a person on a path and a house in the distance.

Do things you enjoy and get out of the house; for example, meet a friend for lunch or take a walk

Blue and grey icon with one person comforting another.

Ask for help from family and friends in caring for your loved one

Illustration of three people with a chat icon in the middle.

Seek out help from a support group or mental health professional

Listen Icon

CAREGIVING FOR A LOVED ONE WITH PROSTATE CANCER

WHERE TO FIND MORE INFORMATION

THE FOLLOWING ORGANIZATIONS OFFER PATIENT AND CAREGIVER SUPPORT

CancerCare®

www.cancercare.org

1-800-813-HOPE

(1-800-813-4673)

PROSTATE CANCER FOUNDATION

www.pcf.org

1-800-757-CURE

(1-800-757-2873)

PROSTATE CANCER RESEARCH INSTITUTE (PCRI)

www.pcri.org

PROSTATE CONDITIONS EDUCATION COUNCIL (PCEC)

www.prostateconditions.org

1-866-4Prost8

(1-866-477-6788)

PROSTATE HEALTH EDUCATION NETWORK (PHEN)

www.prostatehealthed.org

www.rapcancer.org

1-617-481-4020

ZERO—THE END OF PROSTATE CANCER

www.zerocancer.org

1-202-463-9455

More information Less information
More information Less information
More information Less information

IMPORTANT SAFETY INFORMATION

Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

  • have heart problems, high blood pressure, diabetes, or high amounts of fat or cholesterol in your blood (dyslipidemia)
  • have a history of seizures, brain injury, stroke, or brain tumors
  • have kidney or liver problems
  • are pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
  • have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods
  • are breastfeeding or plan to breastfeed. It is not known if NUBEQA passes into breast milk

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

You should not start or stop any medicine before you talk with the healthcare provider that prescribed NUBEQA.

Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.

NUBEQA may cause serious side effects, including:

  • Heart disease. Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with NUBEQA. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with NUBEQA. Call your healthcare provider or get medical help right away if you get chest pain or discomfort at rest or with activity, or shortness of breath during your treatment with NUBEQA
  • Seizure. Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure

The most common side effects of NUBEQA in people with nmCRPC include:

  • increase in liver function tests
  • decreased white blood cells (neutropenia)
     
  • feeling more tired than usual
  • arm, leg, hand, or foot pain
  • rash

The most common side effects of NUBEQA when used in combination with docetaxel in people with mHSPC include:

  • constipation
  • decreased appetite
  • rash
  • bleeding
  • weight gain
  • high blood pressure
  • decreased red blood cells (anemia)
  • high blood sugar levels
  • decreased white blood cells
  • increase in liver function tests
  • low blood calcium levels

NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of NUBEQA.

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see the full Prescribing Information.

WHAT IS NUBEQA®?

NUBEQA® (darolutamide) is a prescription medicine used to treat adults with prostate cancer:

  • that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone (non-metastatic castration-resistant prostate cancer or nmCRPC)
  • or
  • that has spread to other parts of the body and responds to medical or surgical treatment that lowers testosterone (metastatic hormone-sensitive prostate cancer or mHSPC), in combination with docetaxel

It is not known if NUBEQA is safe and effective in women or children.

© 2023 Bayer. All rights reserved. BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer, and Access Services by Bayer is a trademark of Bayer.

Date of last update: 07/20/2023